Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Vertex Pharma receives subpoena from Department of Justice

Vertex Pharmaceuticals Inc said it received a subpoena from the U.S. Department of Justice in the third quarter related to its marketed medicines, seeking documents related primarily to its “good laboratory practices” in a bioanalytical lab. Good laboratory practices are rules that govern non-clinical safety studies, ensuring quality, integrity and reliability of data. Bioanalytical labs […]

Read More »

Basketball players may be at heightened risk of lung clots

(Reuters Health) – Basketball players could be at heightened risk for dangerous blood clots that travel to the lungs, according to a small Spanish study. But the results – calculated from only six cases of so-called pulmonary embolism in U.S. and European players – need to be replicated in larger studies, the authors caution. “We […]

Read More »

Hospitals to pay $250 million for cardiac device coverage violations: DOJ

Hundreds of U.S. hospitals will pay a total of more than $250 million stemming from allegations that they implanted cardiac devices in Medicare patients in violation of coverage requirements, the U.S. Justice Department said on Friday. The 457 hospitals are from 43 states, the Justice Department said. The settlement involves a type of device that […]

Read More »

Regeneron Announces EU Approval of EYLEA (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization

TARRYTOWN, N.Y., Oct. 30, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare has received European approval for EYLEA® (aflibercept) Injection for the treatment of visual impairment due to myopic choroidal neovascularization (myopic CNV). Myopic CNV is an eye disease associated with high degrees of myopia (near-sightedness) and frequently affects people […]

Read More »

AbbVie projects double-digit annual earnings growth through 2020

AbbVie Inc (ABBV.N) reported higher quarterly sales and net income on Friday and forecast double-digit growth of earnings per share through 2020, putting the drugmaker in line to beat Wall Street’s current expectations. AbbVie, which was spun out of Abbott Laboratories in 2013, expects revenue of $37 billion in 2020, which is $5 billion more […]

Read More »

Sanofi Walks Away from a $613 Million Multiple Sclerosis Pact with Glenmark Pharma

PARIS – After experimental multiple sclerosis drug vatelizumab failed to meet its primary endpoints in a mid-stage trial, Sanofi AG (SNY) said it has dropped plans to develop the drug with India-based Glenmark Pharmaceuticals.   During a second-quarter results analysis with media members, Glenmark revealed that Sanofi was terminating the development agreement for vatelizumab, also […]

Read More »

Allergan’s Warner Chilcott Coughs Up $125 Million to Settle Kickback Charges, Former Exec Arrested in Boston

The former president of an Irish drug company was arrested in Boston this morning on charges of conspiring to pay kickbacks to physicians, as his company settled allegations of fraud for $125 million. The U.S. Justice Department said in a release that 57-year-old W. Carl Reichel, the former president of Dublin-based Warner Chilcott, has been […]

Read More »

Novartis, Juno face production hurdles for new blood cancer drugs

As drugmakers including Novartis, Juno Therapeutics and Kite Pharma race to launch what may be the most effective treatments ever seen for leukemia and other blood cancers, they are grappling with how to make them widely available in a reliable and cost-efficient way.   The new therapies, known as CAR T cells, are made by […]

Read More »

FDA approves new Novartis dual combination bronchodilator Utibron Neohaler for patients with chronic obstructive pulmonary disease

– Utibron Neohaler (indacaterol/glycopyrrolate) demonstrated superior and sustained improvements in lung function compared to either of its single bronchodilator components as well as placebo, and improved lung function compared to placebo at 5 minutes after the first dose and throughout the dosing interval.1 It does not replace the use of a rescue inhaler – Utibron […]

Read More »

Intouch Solutions moves NYC office, expands

NEW YORK CITY (OCTOBER 29, 2015) — Intouch Solutions, a marketing agency serving the pharmaceutical industry, has moved their New York offices to 469 Seventh Avenue in Midtown Manhattan. The move comes in response to rapid expansion at Intouch Solutions fueled by the acquisition of a number of major new clients. Employee count in the […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2018 Focus: Top 50 Pharma, Company of the Year and more!

Subscribe

Ad Right Bottom